800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredMethadone Clinics in cities of Ohio
Methadone, Suboxone, and other opioid use disorder treatment in Ohio
Ohio sits at a turning point in its opioid epidemic. Unintentional drug overdose deaths fell from 4,915 in 2022 to 4,447 in 2023, and the Ohio Department of Health’s provisional 2024 data points to the lowest annual death count since 2015. Treatment access is part of why. Across the state, opioid treatment programs (OTPs), office-based prescribers, and telehealth providers offer the three FDA-approved medications for opioid use disorder. Use the listings on this page to find a provider near you, or call the helpline if you want help narrowing it down.
What treatment looks like, and where to get it in Ohio
Three medications are approved for opioid use disorder, and the setting depends on the medication.
Methadone is a long-acting opioid agonist that prevents withdrawal and blocks cravings. In Ohio, methadone for opioid use disorder is dispensed only through an opioid treatment program certified by the Ohio Department of Mental Health and Addiction Services (OhioMHAS). It is not available at retail pharmacies for this use. How methadone treatment works walks through what daily dosing, stabilization, and take-homes look like over time.
Buprenorphine, including the buprenorphine-naloxone combinations sold as Suboxone, Zubsolv, and others, is a partial agonist that eases withdrawal and cravings with a lower overdose risk than full opioids. Since the X-waiver was eliminated in 2023, any clinician in Ohio with a standard DEA registration that includes Schedule III authority can prescribe it from an office, and the prescription is filled at a pharmacy. Extended-release injectable buprenorphine (Sublocade) is given monthly and removes the need to take medication daily. OTPs also offer buprenorphine. If you are weighing the two main options, a side-by-side look at methadone and Suboxone covers the practical differences.
Naltrexone, including the monthly Vivitrol injection, is not a controlled substance and can be prescribed by any licensed Ohio provider. Because it blocks opioids rather than replacing them, treatment can only start after a person has been off opioids for about a week, which a clinician helps plan.
Ohio rules, coverage, and how access is changing
Ohio’s regulatory picture for opioid use disorder treatment changed substantially in 2024 and 2025. Three things matter most for someone trying to get into care.
State rules now match the updated federal framework. OhioMHAS, which serves as Ohio’s State Opioid Treatment Authority, adopted revised Ohio Administrative Code rules for OTPs effective January 31, 2025. The state aligned with SAMHSA’s 2024 revision of 42 CFR Part 8: people in stable treatment can receive up to a 28-day take-home supply of methadone, the prior one-year-of-addiction admission requirement has been removed, mobile medication units are permitted, nurse practitioners and physician assistants can prescribe methadone within an OTP, and a trusted third party can pick up medication for a patient (Center for Community Solutions, 2025; OhioMHAS, 2025). Programs decide take-home eligibility based on stability.
Telehealth. A DEA and HHS final rule that took effect December 31, 2025 made buprenorphine telemedicine initiation permanent, and a fourth temporary extension keeps the broader COVID-era telemedicine flexibilities, including audio-only options for opioid use disorder, in place through December 31, 2026 (Federal Register, 2025). In practice, you can usually start buprenorphine with an Ohio-licensed provider by video, and often by phone, without a prior in-person visit. Methadone for opioid use disorder can be started by audio-video telehealth within an OTP. Rules are still being finalized; staying with your dose and your program matters once you start, so confirm current options with the provider you pick.
Paying for treatment. Ohio Medicaid covers all three medications for opioid use disorder, and managed care plans are required to cover buprenorphine, methadone, and naltrexone without prior authorization (Ohio Department of Medicaid, 2021 State Plan Amendment). Medicare, most commercial insurance, and self-pay are also accepted across the directory, with sliding-scale fees at many programs. Privacy at work is a common concern; federal confidentiality rules protect substance use disorder treatment records.
Ohio’s overdose picture, in plain numbers
The Ohio Department of Health reported 4,447 unintentional drug overdose deaths in 2023, down 9.5% from 2022. Fentanyl was involved in 78% of those deaths. Harm Reduction Ohio’s analysis of state mortality data projects the 2024 total at roughly 3,500, which would be the lowest since 2015 and a roughly one-third drop from 2023. Researchers attribute most of the decline to a drop in fentanyl in Ohio’s drug supply, with naloxone distribution and treatment access contributing meaningfully alongside it (Harm Reduction Ohio, 2025; Cuyahoga County Board of Health, 2025).
The progress is real, and so is the risk. Fentanyl still dominates the supply, and most of the 2023 deaths involved more than one substance. Medication treatment is the strongest evidence-based protection against opioid overdose, and the listings above are where you start. Understanding opioid use disorder explains why the medications work and what recovery realistically looks like.
How to start treatment in Ohio
Most people begin with a phone call to a program on this page. The first appointment is an intake assessment, where a clinician confirms diagnosis, asks about medical and substance use history, and discusses which medication and setting fit your situation. Some Ohio programs offer same-day or next-day medication starts; others schedule a few days out. Bring an ID if you have one, your insurance card, and a list of current medications. If you do not have insurance or ID, ask anyway; programs frequently work around this.
If you have been using illicit fentanyl, the start of buprenorphine needs to be timed carefully. Starting too soon after fentanyl can cause sudden, severe withdrawal (precipitated withdrawal). Clinicians manage this with several approaches, including a slower, low-dose start. Methadone induction does not carry this risk, which is one reason some people in Ohio start with methadone after heavy fentanyl use. A walk-through of opioid use disorder treatment covers what to expect over the first weeks. Higher-acuity situations, including a need for medically managed withdrawal, may call for a brief inpatient stabilization before outpatient treatment continues.
Pregnancy, reentry, and other specific situations
Pregnancy is a clinical priority, not a reason to delay care. Methadone and buprenorphine are the recommended standard of care during pregnancy because they stabilize the parent and protect the pregnancy from withdrawal. Ohio’s Plan of Safe Care framework, administered through county Children Services agencies and prenatal providers, focuses on supporting families rather than separating them, and treatment is a central part of that plan. If fear of child welfare involvement is keeping you out of care, raise it with a provider before your first appointment so they can walk you through what reporting actually requires. Methadone during pregnancy covers dosing changes, neonatal opioid withdrawal syndrome (NOWS), and what hospital delivery looks like.
For Ohioans leaving jail or prison, the January 2025 OhioMHAS rule changes specifically expanded medication delivery into carceral and residential settings so treatment can continue without a gap at release. Ask the program you call whether they coordinate with a county jail or state facility; many do. Family members helping someone start treatment have a real role in this; people with family support stay in treatment longer.
Naloxone and overdose safety in Ohio
Naloxone, sold over the counter as Narcan, reverses an opioid overdose. In Ohio it is free through Project DAWN (Deaths Avoided With Naloxone), run by the Ohio Department of Health and OhioMHAS. The Ohio Department of Health distributed 291,722 naloxone kits through Project DAWN in 2023, with reported reversals climbing to 20,368 that year. Free kits are available by mail through Naloxone.Ohio.gov and in person from local Project DAWN sites, which include county health departments and partner organizations across the state. Ohio’s Good Samaritan provisions (Ohio Revised Code 2925.11) offer limited protection from minor drug possession charges for both the person overdosing and the person who calls for help. A return to use can happen on the path to recovery; overdose prevention while in treatment covers what to keep in the house and how to use naloxone.
Frequently asked questions
Does Ohio Medicaid cover Suboxone and methadone?
Yes. Ohio Medicaid and its managed care plans cover all three FDA-approved medications for opioid use disorder, including buprenorphine and Suboxone, methadone, and naltrexone, without prior authorization (Ohio Department of Medicaid). Coverage applies whether the medication is dispensed at a pharmacy or through an opioid treatment program.
Can I start Suboxone by telehealth in Ohio?
For most people, yes. Current federal rules allow buprenorphine to be started through telehealth, including by phone in many cases, without a prior in-person visit. These flexibilities run through at least December 31, 2026, and the buprenorphine-specific final rule that took effect December 31, 2025 is permanent. Confirm options with an Ohio-licensed provider, since some clinics still prefer a first visit in person.
Do I have to go to a clinic every day for methadone?
At the start, usually yes. As you stabilize, your program can authorize take-home doses on a schedule that grows over time, up to a 28-day supply under Ohio and federal rules. Eligibility depends on stability, and the program decides based on its assessment.
What is the difference between an OTP and an office-based provider?
An opioid treatment program (OTP) is certified by OhioMHAS and SAMHSA to dispense methadone on site and may also offer buprenorphine and naltrexone. An office-based opioid treatment (OBOT) practice prescribes buprenorphine or naltrexone, which you fill at a pharmacy. Neither setting is better in the abstract. The right fit depends on which medication you and your clinician choose and how much structure helps you.
What if I’m in a rural Ohio county with no OTP nearby?
You have options. Office-based buprenorphine providers practice in most Ohio counties, and telehealth lets a licensed Ohio prescriber start and continue buprenorphine remotely. Some OTPs operate mobile medication units that bring methadone closer to underserved areas, a flexibility expanded under Ohio’s 2025 rule update. Call the helpline if you cannot find a local match in the listings.
Can naltrexone or Vivitrol replace methadone or Suboxone?
Naltrexone is a different approach, not a direct substitute. It blocks opioids rather than easing withdrawal and cravings the way methadone and buprenorphine do, and it requires being off opioids for about a week before the first dose. For some people it is the right fit; for others, methadone or buprenorphine retains better. More common questions covers comparison details in plain language.
Sources and review
Last reviewed: June 2026.
- Substance Abuse and Mental Health Services Administration. Medications for Substance Use Disorders.samhsa.gov
- Drug Enforcement Administration and HHS. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, Federal Register, December 31, 2025. federalregister.gov
- Ohio Department of Health. 2023 Unintentional Drug Overdose Annual Report, October 2024. odh.ohio.gov
- Harm Reduction Ohio. Ohio overdose deaths down by nearly one-third in 2024, analysis of ODH mortality data, 2024 to 2025. harmreductionohio.org
- Center for Community Solutions. New opioid treatment program rules in effect in Ohio, March 2025. communitysolutions.com
- Ohio Department of Medicaid. State Plan Amendment OH-21-0010, Section 1006(b) SUPPORT Act MAT Coverage, 2021. medicaid.gov
- Ohio Department of Health. Project DAWN.odh.ohio.gov
- Cuyahoga County Board of Health. Understanding Ohio’s Decline in Fentanyl-Related Deaths, January 2025. ccbh.net
Methadone Centers is an educational and treatment-discovery resource, not a healthcare provider. We do not provide medical advice, diagnosis, or treatment. Decisions about which medication, setting, and program fit your situation should be made with a qualified clinician.
The helpline featured on this site is offered by a sponsored treatment provider and may not include every program in the directory. Calls are routed to that provider; there is no obligation to enroll. If you prefer, you can call any listed program directly using the contact information on its listing.